ClinicalSlideSet.BreastCancerScreeningandPrevention.pptVIP

ClinicalSlideSet.BreastCancerScreeningandPrevention.ppt

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
ClinicalSlideSet.BreastCancerScreeningandPrevention

Clinical Bottom Line: Risk Assessment... Breast cancer is common among U.S. women and increases with age. Other factors that increase this risk include the duration of endogenous estrogen (which can be approximated by the age of menopause), breast density, proliferative breast disease, and family history. Genetic mutations are uncommon but increase risk substantially. Online calculators can help assess risk. We recommend that clinicians conduct a periodic risk assessment, including collection of family history at least every 5 years as a first step in mitigating high risk and to develop an individualized screening plan. * Who should be screened for breast cancer? Since many women who develop breast cancer do not fall into a clear high-risk group and because of the strong connection between age and risk of breast cancer, a consensus has emerged that women should undergo screening for breast cancer using primarily age-based protocols. High-risk women may benefit from modifications of these protocols. No low-risk groups (other than young age) have been identified in which screening can clearly be omitted. * Is breast cancer screening effective in reducing mortality? Eight large randomized trials (sometimes broken into 9–11 separate components) have studied mammography screening in the general population, including about 600 000 women from the United States, Canada, United Kingdom, and Sweden. These studies were somewhat heterogeneous with regard to the age groups included, methods of randomization, intervals between screening, and methods of analysis. Nonetheless, meta-analyses have shown that when compared with controls, groups offered screening had a 15%–20% reduction in risk for breast cancer mortality among all age groups (6, 17). For women aged 40–59 years, the reduction in was smaller in magnitude and less statistically significant (Table 3) (17). For women aged 60–69 years, the reduction was highly significant. For women aged 70–74 years, the reduction was not

文档评论(0)

75986597 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档